Merck & Co. Inc.

NYSE: MRK · Real-Time Price · USD
84.69
1.93 (2.33%)
At close: Aug 15, 2025, 2:46 PM

Merck & Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
17.45B 17.13B 12.16B 13.75B 2.31B 365M 4.61B 3.12B 13.04B 14.53B 15.33B 16.65B 13.48B 11.92B 6.01B 4.38B 6.61B
Depreciation & Amortization
4.61B 4.5B 4.27B 4.09B 3.87B 3.87B 3.8B 3.75B 3.78B 3.91B 3.85B 3.65B 3.4B 3.18B 3.25B 3.34B 3.7B
Stock-Based Compensation
780M 761M 741M 710M 676M 645M 623M 598M 566M 541M 515M 493M 488M 479M 481M 480M 453M
Other Working Capital
-285M -3.67B -1.67B -2.07B -2.7B -2.21B -1.93B -3.85B -3.61B -2.02B -2.48B -2.88B -3.03B -3.93B -3B -4.3B -3.28B
Other Non-Cash Items
-298M 3.99B 4.33B 1.71B 12.28B 12.23B 12.13B 13.83B 4.17B 4.47B 3.58B 1.42B 2.89B 2.25B 7.02B 7.3B 4.56B
Deferred Income Tax
-1.38B -1.25B -1.56B -1.5B -1.67B -1.9B -1.27B -1.6B -1.51B -1.57B -1.1B -442M -141M 215M -659M -733M -732M
Change in Working Capital
-285M -3.67B -1.67B -2.07B -2.7B -2.21B -2.7B -4.61B -4.37B -2.78B -2.48B -2.88B -3.03B -3.93B -3B -4.3B -3.28B
Operating Cash Flow
20.88B 21.47B 18.26B 16.69B 14.76B 13.01B 17.19B 15.07B 15.67B 19.09B 19.7B 18.89B 17.08B 14.11B 13.08B 10.46B 11.34B
Capital Expenditures
-3.84B -3.37B -3.42B -3.54B -3.72B -3.86B -4.02B -4.25B -4.41B -4.39B -4.45B -4.49B -4.3B -4.45B -4.75B -5.1B -4.83B
Cash Acquisitions
-3.35B -4.09B -4.09B 156M -10.55B -11.13B -11.13B -12.15B -1.45B -121M -11.38B -11.26B -12.89B -12.91B -4.8B -5.38B -4.08B
Purchase of Investments
-1.19B -519M -315M -432M -408M -955M -1.2B -1.09B -1.39B -1.2B -710M 467M 800M 1.17B 154M -1.02B -1.05B
Sales Maturities Of Investments
573M 377M 539M 1.19B 1.42B 1.66B 1.5B 1.13B 1.22B 721M 1.24B 1.01B 641M 1.03B 1.42B 1.31B 1.38B
Other Investing Acitivies
-43M -127M 1.05B -100M 156M 207M -1.03B -158M -113M 32M 43M -1.08B -1.24B -1.4B -1.3B -183M 19M
Investing Cash Flow
-7.84B -7.73B -6.24B -2.73B -13.1B -14.08B -15.88B -16.51B -6.15B -4.96B -15.26B -15.36B -16.99B -16.55B -9.28B -10.38B -8.55B
Debt Repayment
3.06B 2.31B 2.85B 901M 3.43B 4.18B 4.19B 5.13B -1B -2.25B 4.52B 5.52B 746M 1.63B -2.28B -4.58B 3.01B
Common Stock Repurchased
-2.35B -1.31B -1.21B -1.23B -1.32B -1.35B -1.22B -762M -424M -275M -28M -601M -840M -840M -822M -239M n/a
Dividend Paid
-7.94B -7.84B -7.74B -7.64B -7.54B -7.45B -7.34B -7.24B -7.12B -7.01B -6.91B -6.81B -6.71B -6.61B -6.51B -6.41B -6.31B
Other Financial Acitivies
-2.76B -195M -162M -138M -143M -203M -9M 39M 87M 47M -49M -136M 8.41B 8.41B 8.37B 8.38B -173M
Financial Cash Flow
-9.97B -7.03B -6.27B -8.11B -5.57B -4.81B -4.12B -2.55B -8.09B -9.12B -2.36B -1.93B 1.6B 2.59B -1.24B -2.82B -3.44B
Net Cash Flow
3.06B 6.41B 6.02B 5.66B -4.12B -5.86B -2.61B -4.04B 1.17B 4.61B 1.23B 1.12B 1.58B -11M 2.63B -2.53B -437M
Free Cash Flow
17.04B 18.1B 14.84B 13.15B 11.04B 9.14B 13.17B 10.83B 11.26B 14.71B 15.25B 14.4B 12.78B 9.66B 8.33B 5.36B 6.5B